Clinical Trials

Phase 4 Not yet recruiting

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT07314424 2026-01-02

The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor

160 enrolled

Classical hematologySarcoma

Anemia, Bone Neoplasms

NCT05732961 2025-12-10

Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

70 enrolled

Phase 3 Active not recruiting

Anemia, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT02048813 2025-11-28

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

529 enrolled 12 charts 2 FDA

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07025512 2025-11-14

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

40 enrolled

Classical hematologyMyeloidPlasma cell

Cytopenia, Anemia, Thrombocytopenia

NCT04582539 2025-10-22

LIMBER

Phase 1/2 Terminated

22 enrolled 28 charts

Anemia, Multiple Myeloma, Myelodysplastic Syndromes

NCT06018883 2025-08-07

PTCA199-3

Phase 3 Active not recruiting

100 enrolled

Phase 3 Active not recruiting

Anemia

NCT04717414 2025-07-10

INDEPENDENCE

313 enrolled

Classical hematologyDermatologic

Anemia, Myeloproliferative Disorders, Primary Myelofibrosis

NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Phase 2 Withdrawn

Anemia, Melanoma, Anemia, Iron-Deficiency

NCT04103645 2025-07-02

Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients

2 enrolled 12 charts

Classical hematologyOther hematologic neoplasm

Anemia, Myeloproliferative Disorders

NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Phase NA Withdrawn

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT05407987 2025-04-25

FORGE II

Phase 3 Recruiting

82 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Anemia, Iron-Deficiency

NCT06245746 2025-03-21

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Phase 1 Recruiting

9 enrolled

Anemia, Hemorrhage, Infections, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT05634005 2025-03-06

Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence

Phase NA Completed

1,543 enrolled

Classical hematologyLymphoid

Afibrinogenemia, Anemia, Lymphoma, Follicular, Thrombocytopenia, Hemostatic Disorders

NCT03891576 2025-01-17

Newton

Classical hematologyGynecologic

83 enrolled

Anemia, Fallopian Tube Neoplasms, Neutropenia, Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT06737081 2024-12-17

SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

60 enrolled

Anemia

NCT01284348 2024-08-29

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Classical hematologyGenitourinaryGynecologicHead & NeckThoracic

26 enrolled 18 charts

Anemia, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Small Cell Lung Carcinoma

NCT00875004 2024-06-26

PLATON

Phase NA Terminated

27 enrolled

Anemia

NCT03837171 2024-06-25

TRANSPORT

Phase 3 Completed

192 enrolled

Anemia, Neoplasms, Shock, Septic

NCT06018896 2024-06-06

PTCA199-4

Classical hematologyGastrointestinal

20 enrolled

Anemia, Pancreatic Neoplasms

NCT02101944 2024-05-17

Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

12 enrolled

Classical hematologyPlasma cell

Anemia, Multiple Myeloma

NCT00310232 2024-04-02

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)

Phase 3 Terminated

70 enrolled

Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

2 enrolled

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01712308 2023-10-10

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

Phase 2 Completed

56 enrolled 9 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

NCT03733249 2023-09-26

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Phase 1/2 Terminated

187 enrolled 8 charts

Primary Immunodeficiency Diseases, Cytopenia, Anemia, Anemia, Aplastic, Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Anemia, Diamond-Blackfan, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00931606 2023-09-13

MK-7962-012

30 enrolled 32 charts

Anemia, Neoplasm Metastasis, Neoplasms

NCT03194542 2023-08-24

A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

Phase 2 Completed

95 enrolled 32 charts